Index of reports
> Life Threatening Events (128)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zyprexa (Olanzapine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 128 Next >>
Possible Zyprexa side effects in 62 year old male
Reported by a individual with unspecified qualification from United States on 2012-08-22
Patient: 62 year old male, weighing 93.4 kg (205.6 pounds)
Reactions: Sedation, Fall, Somnolence, Asthenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Possible Zyprexa side effects in 17 year old male
Reported by a consumer/non-health professional from Venezuela on 2012-08-13
Patient: 17 year old male
Reactions: Agitation, Mydriasis, Intentional Overdose, Suicide Attempt, Depressed Level of Consciousness, Unevaluable Event
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Dosage: 110 mg, unk
Start date: 2012-07-17
End date: 2012-07-17
Zyprexa
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2011-11-01
End date: 2012-07-17
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from France on 2012-08-03
Patient: male
Reactions: Mydriasis, Respiratory Disorder, Central Nervous System Lesion, Ischaemic Stroke, Cerebellar Syndrome, Cerebellar Haematoma, Bladder Dilatation, Pulmonary Congestion, Depression, Hypertension, Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Risperdal; Polyethylene Glycol; Tercian; Loxapine HCL; Risperdal Consta; Escitalopram; Risperdal; Lepticur; Imovane
Possible Zyprexa side effects in 19 year old male
Reported by a physician from Switzerland on 2012-07-31
Patient: 19 year old male
Reactions: Agitation, Yawning, Hallucination, Auditory, Dementia, Tachycardia, Hypotension, Opisthotonus, Encephalopathy, Abnormal Behaviour, Speech Disorder, Bradycardia, Gait Disturbance, Altered State of Consciousness, Hypertension, Acute Disseminated Encephalomyelitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Haloperidol; Haloperidol
Possible Zyprexa side effects in male
Reported by a physician from Japan on 2012-07-26
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Off Label Use, Psychomotor Hyperactivity, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Diazepam; Depakene; Levetiracetam; Silece; Levetiracetam; Tegretol; Lendormin; Valproate Sodium
Possible Zyprexa side effects in male
Reported by a physician from France on 2012-07-26
Patient: male
Reactions: Agranulocytosis, Transplant Rejection, Toxicity To Various Agents, Pericardial Effusion
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Cellcept; Perindopril Erbumine
Possible Zyprexa side effects in 56 year old female
Reported by a consumer/non-health professional from United States on 2012-07-24
Patient: 56 year old female, weighing 81.6 kg (179.6 pounds)
Reactions: Back Pain, Neck Pain, Renal Transplant, Urinary Tract Infection, Blood Potassium Increased, Type 1 Diabetes Mellitus
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Effexor XR
Dosage: 125 mg 1 daily oral
Administration route: Oral
Indication: Depression
Start date: 2002-01-01
End date: 2012-02-01
Latuda
Seroquel
Zyprexa
Dosage: 15 mg 1 day oral
Administration route: Oral
Indication: Schizoaffective Disorder
Possible Zyprexa side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-23
Patient: male
Reactions: Ischaemic Stroke, Psychiatric Decompensation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Loxapine HCL
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-12-02
End date: 2010-12-08
Risperdal
Administration route: Oral
Start date: 2010-11-23
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-12-16
Risperdal Consta
Indication: Persecutory Delusion
Start date: 2010-12-03
End date: 2010-12-03
Tercian
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-12-02
Zyprexa
Administration route: Oral
Indication: Persecutory Delusion
Start date: 2010-07-09
End date: 2010-11-23
Other drugs received by patient: Imovane; Lepticur; Lepticur; Polyethylene Glycol; Escitalopram
Possible Zyprexa side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-19
Patient: 53 year old male
Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.4 mg, 2 in 1 d
Administration route: Oral
Indication: Anxiety Disorder
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Carbidopa
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V
Possible Zyprexa side effects in
Reported by a physician from Australia on 2012-07-19
Patient:
Reactions: Electrocardiogram QT Prolonged, Cardiac Murmur, Foetal Exposure During Pregnancy, Bradycardia Neonatal, Foetal Distress Syndrome, Amniotic Fluid Volume Decreased, Type 1 Diabetes Mellitus, Hypothermia Neonatal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Dosage: 10 mg, each evening
Start date: 2010-06-01
Zyprexa
Dosage: 10 mg, each evening
Start date: 2010-06-01
Possible Zyprexa side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13
Patient: 53 year old male
Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Alprazolam
Dosage: 0.4 mg, 2 in 1 d
Administration route: Oral
Indication: Anxiety Disorder
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Dopacol
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V
Possible Zyprexa side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-11
Patient: 53 year old male
Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Dopacol
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Alprazolam; Rinderon-V
Possible Zyprexa side effects in 34 year old male
Reported by a physician from Japan on 2012-07-10
Patient: 34 year old male
Reactions: Agitation, Blood Creatine Phosphokinase Increased, Procalcitonin Increased, Blood Urea Increased, Body Temperature Increased, Delirium, Convulsion, Critical Illness Polyneuropathy, C-Reactive Protein Increased, Oliguria, Heart Rate Increased, Blood Pressure Decreased, Enterocolitis, Blood Creatinine Increased, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Lithium Carbonate; Valproate Sodium; Brotizolam; Quetiapine; Flunitrazepam
Possible Zyprexa side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10
Patient: 53 year old male
Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cabergoline
Dosage: 1 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Carbidopa + Levodopa
Dosage: 87.5 mg, 6 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-07-20
Comtan
Dosage: 100 mg, 1 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Donepezil HCL
Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-06-23
End date: 2011-07-04
Donepezil HCL
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Start date: 2011-07-05
End date: 2012-06-21
Pramipexole Dihydrochloride
Dosage: 0.25 mg, 1 in 1 d
Administration route: Oral
Start date: 2012-01-18
Pramipexole Dihydrochloride
Dosage: 1 mg, 2 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 25 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-21
End date: 2012-06-23
Symmetrel
Dosage: 50 mg, 4 in 1 d
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-06-19
Zyprexa
Dosage: 5 mg, 1 in 1 d
Administration route: Oral
Indication: Psychiatric Symptom
Start date: 2012-06-23
Other drugs received by patient: Rinderon-V; Alprazolam
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from Japan on 2012-06-29
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Off Label Use, Psychomotor Hyperactivity, Dehydration, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Diazepam; Valproate Sodium; Levetiracetam; Silece; Depakene; Levetiracetam; Tegretol; Lendormin
Possible Zyprexa side effects in 34 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-28
Patient: 34 year old male
Reactions: Blood Creatine Phosphokinase Increased, Disseminated Intravascular Coagulation, Diabetic Ketoacidosis, Acute Respiratory Failure, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Possible Zyprexa side effects in male
Reported by a physician from France on 2012-06-27
Patient: male
Reactions: Agranulocytosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cellcept
Administration route: Oral
Indication: Heart Transplant
End date: 2012-05-22
Perindopril Erbumine
Indication: Hypertension
End date: 2012-05-22
Zyprexa
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2012-02-15
End date: 2012-05-21
Other drugs received by patient: Solu-Medrol; Prograf; Neoral
Possible Zyprexa side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Zyprexa side effects in 34 year old male
Reported by a physician from Japan on 2012-06-20
Patient: 34 year old male
Reactions: Agitation, Procalcitonin Increased, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Body Temperature Increased, Delirium, Convulsion, Critical Illness Polyneuropathy, C-Reactive Protein Increased, Oliguria, Heart Rate Increased, Blood Pressure Decreased, Blood Creatinine Increased, Enterocolitis, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Brotizolam; Lithium Carbonate; Flunitrazepam; Quetiapine; Valproate Sodium
Possible Zyprexa side effects in male
Reported by a physician from France on 2012-06-19
Patient: male
Reactions: Overdose, Agranulocytosis, Heart Transplant Rejection, Toxicity To Various Agents
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cellcept
Administration route: Oral
Indication: Heart Transplant
End date: 2012-05-22
Perindopril Erbumine
Indication: Hypertension
End date: 2012-05-22
Zyprexa
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2012-02-15
End date: 2012-05-21
Other drugs received by patient: Neoral; Prograf; Solu-Medrol
Possible Zyprexa side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-15
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Glucose Tolerance Impaired, Hepatic Steatosis
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Zyprexa
Possible Zyprexa side effects in 32 year old female
Reported by a consumer/non-health professional from Germany on 2012-06-12
Patient: 32 year old female
Reactions: Drug Level Above Therapeutic, Overdose, Suicide Attempt, Respiratory Depression, Suicidal Ideation, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Citalopram Hydrobromide
Possible Zyprexa side effects in 34 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-07
Patient: 34 year old male
Reactions: Blood Creatine Phosphokinase Increased, Disseminated Intravascular Coagulation, Diabetic Ketoacidosis, Acute Respiratory Failure, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Possible Zyprexa side effects in female
Reported by a consumer/non-health professional from France on 2012-06-04
Patient: female
Reactions: Hepatitis B Surface Antibody Positive, Hepatic Steatosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Imovane; Citalopram Hydrobromide; Risperdal
Possible Zyprexa side effects in male
Reported by a physician from Japan on 2012-05-29
Patient: male, weighing 50.0 kg (110.0 pounds)
Reactions: Polydipsia, Carcinoembryonic Antigen Increased, Rectal Cancer, Platelet Count Decreased, Electrolyte Imbalance, Thirst, Urinary Retention, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Ferotym; Besacolin; Valproate Sodium; Flunitrazepam; Ubtec; Tamsulosin Hydrochloride; Cefazolin Sodium; Zolpidem; Mecobalamin; Gamofa; Magnesium Sulfate
Possible Zyprexa side effects in male
Reported by a physician from France on 2012-05-25
Patient: male, weighing 104.0 kg (228.8 pounds)
Reactions: Rhabdomyolysis, Coma, Renal Tubular Necrosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Lexomil; Amlodipine Besilate W / Olmesartan Medoxomil; Depakote; Naproxen; Colchicine
Possible Zyprexa side effects in female
Reported by a physician from Italy on 2012-05-18
Patient: female
Reactions: Incontinence, Rhabdomyolysis, Gastrooesophageal Reflux Disease, Fall, Haematemesis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Rosuvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2008-01-01
End date: 2011-12-03
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Start date: 1997-01-01
End date: 2011-12-03
Other drugs received by patient: Ramipril; Lansoprazolo (Lansoprazole); Metoprololo (Metorprolol); Aspirin; Nitriglicerina (Nitroglycerin)
Possible Zyprexa side effects in male
Reported by a physician from France on 2012-05-17
Patient: male
Reactions: Liver Injury, Road Traffic Accident, Neuroleptic Malignant Syndrome, Leukocytosis, Shock, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Zyprexa
Other drugs received by patient: Stablon; Lepticur
Page 1 Next >>
|